Global Single Nucleotide Polymorphism Genotyping Market US$ 5 Billion by 2021

Global Single Nucleotide Polymorphism Genotyping Market US$ 5 Billion by 2021

The global single nucleotide polymorphism genotyping market is estimated to reach US$ 4.1 Billion in 2020, growing at a CAGR of 22.3% from 2017 to 2021, according to a market research report Single Nucleotide Polymorphism Genotyping Market 2017-2021, published by iHealthcareAnalyst, Inc.

Visit the Single Nucleotide Polymorphism Genotyping Market 2017-2021 report at https://www.ihealthcareanalyst.com/report/single-nucleotide-polymorphism-genotyping-market/

The global single nucleotide polymorphism genotyping market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global single nucleotide polymorphism genotyping market segmentation is based on technologies (AB SNPlex, MassARRAY MALDI-TOF, SNP by Pyrosequencing, SNP GeneChips and Microarrays, Taqman Allelic Discrimination, and applications (agricultural biotechnology, breeding and animal livestock, diagnostic research, pharmaceuticals and pharmacogenomics).

The global single nucleotide polymorphism genotyping market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global single nucleotide polymorphism genotyping market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

  1. Technology
    • AB SNPlex
    • MassARRAY (MALDI-TOF)
    • SNP by Pyrosequencing
    • SNP GeneChips and Microarrays
    • Taqman Allelic Discrimination
    • Others
  1. Application
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
    • Diagnostic Research
    • Pharmaceuticals and Pharmacogenomics
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Affymetrix, Inc.
    • Douglas Scientific LLC
    • Fluidigm
    • Illumina, Inc.
    • Life Technologies Corporation
    • PREMIER Biosoft
    • ThermoFisher Scientific
    • Sequenom, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2017-11-05T09:58:07+00:00 Categories: Press Releases|